Results 121 to 130 of about 56,899 (289)

Diagnosis and Treatment of Bicuspid Aortic Valve Disease

Erciyes Tıp Dergisi/Erciyes Medical Journal, 2015
Bicuspid aortic valve disease is the most common congenital cardiac anomaly. The prevalence in the general population is between 0.46% and 1.37%. There is significantly high cardiac morbidity associated with bicuspid aortic valve disease, predomi- nantly due to progressive valve dysfunction (stenosis or regurgitation) that requires surgical ...
Mehmet Akif Cakar, Ercan Aydin
openaire   +2 more sources

Endothelial Notch1 Is Required for Proper Development of the Semilunar Valves and Cardiac Outflow Tract

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2016
BackgroundCongenital heart disease is the most common type of birth defect, affecting ≈2% of the population. Malformations involving the cardiac outflow tract and semilunar valves account for >50% of these cases predominantly because of a bicuspid aortic
Sara N. Koenig, Kevin Bosse, Uddalak Majumdar, Elizabeth M. Bonachea, Freddy Radtke, Vidu Garg   +5 more
doaj   +1 more source

Risk factors for paravalvular leak after transcatheter aortic valve replacement [PDF]

, 2019
Objective. To assess risk factors for paravalvular leak (PVL) after transcatheter aortic valve implantation (TAVI) in a large single-center cohort, including measurement of aortic valve calcification using a reproducible method. Methods.
Pollari, Francesco
core  

Disrupted Slit-Robo signalling results in membranous ventricular septum defects and bicuspid aortic valves. [PDF]

, 2015
The mesenchymal cushions lining the early embryonic heart undergo complex remodelling to form the membranous ventricular septum as well as the atrioventricular and semilunar valves in later life.
Andrews, WD, Mommersteeg, MT, Parnavelas, JG, Yeh, ML   +3 more
core   +1 more source

Transfemoral Transcatheter Aortic Valve Implantation (TF‐TAVI) for Patients With Left Ventricular Assist Device (LVAD) and Aortic Regurgitation

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Aortic regurgitation (AR) develops in up to 25%−30% of patients with left ventricular assist device (LVAD). Treatment remains challenging since surgery confers significant peri‐operative risk and the lack of valvular calcification renders transfemoral transcatheter aortic valve implantation (TF‐TAVI) with non‐dedicated devices technically ...
Daniel Tai‐Leung Chan, Ho‐On Alston Conrad Chiu, Ka‐Lam Wong, Ka‐Chun Un, Kwong‐Yue Eric Chan, Shu‐Yue Sze, Chor‐Cheung Frankie Tam, On‐Yat Wong, Gilbert H. L. Tang, Simon Cheung‐Chi Lam   +9 more
wiley   +1 more source

The living aortic valve: From molecules to function. [PDF]

, 2014
The aortic valve lies in a unique hemodynamic environment, one characterized by a range of stresses (shear stress, bending forces, loading forces and strain) that vary in intensity and direction throughout the cardiac cycle.
Bertazzo, S, Butcher, JT, Chester, AH, El-Hamamsy, I, Latif, N, Yacoub, MH   +5 more
core   +1 more source

Interventional therapies for chronic heart failure: An overview of recent developments

ESC Heart Failure, Volume 12, Issue 2, Page 1081-1094, April 2025.
Abstract Heart failure (HF), the final manifestation of most cardiovascular diseases, has become a major global health concern, affecting millions of individuals. Despite basic drug treatments, patients present with high morbidity and mortality rates. However, recent advancements in interventional therapy have shown promising results in improving the ...
Bingchen Guo, Si Shi, Yutong Guo, Jie Xiong, Bo Wang, Zengxiang Dong, Dianyu Gao, Yingfeng Tu   +7 more
wiley   +1 more source

Expert consensus recommendations on the cardiogenetic care for patients with thoracic aortic disease and their first-degree [PDF]

, 2018
Background: Thoracic aortic aneurysm (TAA) is a potentially life-threatening disorder with a strong genetic component. The number of genes implicated in TAA has increased exponentially over the last decade.
Bekkers, S.C.A.M., Bouma, B.J. (Berto J.), Cozijnsen, L. (Luc), Duijnhouwer, A.L. (Anthonie L.), Hilhorst-Hofstee, Y. (Yvonne), Kempers, M.J.E. (Marlies), Kerstjens-Frederikse, W.S. (Wilhelmina), Lambermon, E. (Eric), Loeys, B.L. (Bart), Post, J. (Johan), Roos-Hesselink, J.W. (Jolien), van Brakel, T.J. (Thomas J.), van de Laar, I.M.B.H. (Ingrid M.B.H.), Verhagen, J.M.A. (Judith), Wessels, M.W. (Marja)   +14 more
core   +1 more source

Increased calcification by erythrophagocytosis in aortic valvular interstitial cells

ESC Heart Failure, Volume 12, Issue 2, Page 1469-1473, April 2025.
Abstract Background Calcific aortic valve disease (CAVD) progresses over time to severe aortic stenosis and eventually heart failure. Recent evidence indicates that intraleaflet haemorrhage (ILH) strongly promotes CAVD progression. However, it remains poorly understood how it mechanistically contributes to valvular calcification.
Zihan Qin, Magnus Bäck, Anders Franco‐Cereceda, Sven‐Christian Pawelzik   +3 more
wiley   +1 more source

A very rare case of late diagnosis of cor triatriatum sinistrum [PDF]

, 2018
L
Czerny, Martin, Jurko, Alexander, Minarik, Milan, Schusterova, Ingrid   +3 more
core   +1 more source